Neuropsychiatric features of corticobasal degeneration

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 5, 1998, Pages 717-721

  Litvan, Irene ^a,b   Cummings, Jeffrey L ^c,d   Mega, Michael ^c  

^a Neuropharmacology Unit   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c Department of Neurology ^*

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corticobasal degeneration; Neurobehaviour; Progressive supranuclear palsy

Indexed keywords

AGED; AGITATION; APATHY; ARTICLE; BASAL GANGLION; BEHAVIOR DISORDER; BRAIN CORTEX ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; IRRITABILITY; MALE; MOTOR DYSFUNCTION; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RATING SCALE; SEMANTICS; STATISTICAL ANALYSIS;

EID: 0031733381     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.5.717     Document Type: Article

References (40)

1. Rinne JO, Lee MS, Thompson PD, et al. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994;117:1183-96.
2. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology 1997;48:119-25.
3. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995;146:1388-96.
4. Lang AE, Bergeron C, Pollanen MS, et al. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436-40.
5. Jendroska K, Rossor MN, Mathias CJ, et al. Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report. Mov Disord 1995;10: 111-4.
6. Bergeron C, Pollanen MS, Weyer L, et al. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996;40:893-900.
7. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease, and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55:53-67.
8. Bergeron C, Pollanen MS, Weyer L, et al. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurology 1997;56:726-34.
9. Schneider JA, Watts RL, Gearing M, et al. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997;48:959-69.
10. Brunt ER, van Weerden TW, Pruim J, et al. Unique myoclonic pattern in corticobasal degeneration. Mov Disord 1995;10:132-42.
11. Thompson PD, Day BL, Rothwell JC, et al. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 1994;117:1197-207.
12. Leiguarda R, Lees AJ, Merello M, et al. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 1994;57:455-9.
13. Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45:1477-83.
14. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35: 420-6.
15. Rey GJ, Tomer R, Levin BE, et al. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord 1995;10:106-10.
16. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 corticobasal degeneration cases: a clinicopathologic study. J Neurol Neurosurg Psychiatry 1998, 64:184-9.
17. Steele C, Rovner B, Chase GA, et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990;147:1049-51.
18. Morriss RK, Rovner BW, Folstein MF, et al. Delusions in newly admitted residents of nursing homes. Am J Psychiatry 1990;147:299-302.
19. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-9.
20. Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-71.
21. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatrie Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14.
22. Litvan I, Mega MS, Cummings JL, et al. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1997; 47:1184-9.
23. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
24. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric psychiatry. New York: Grune and Stratton, 1976.
25. Fahn S, Elton RL, and members of the UPDRS Committee. Unified Parkinson's disease rating scale. Florham Park, NJ: Macmillan Healthcare Information, 1987:153-64.
26. Efron B, Tibshirani R. Statistical data analysis in the computer age. Science 1991;253:390-5.
27. Santamaria J, Tolosa E, Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986;36:1130-3.
28. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-54.
29. Cummings JL, Diaz C, Levy M, et al. Neuropsychiatrie syndromes in neurodegenerative diseases: frequency and significance. Seminars in Clinical Neuropsychiatry 1996;1: 241-7.
30. Starkstein SE, Preziosi TJ, Bolduc PL, et al. Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31.
31. Starkstein SE, Mayberg HS, Leiguarda R, et al. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377-82.
32. Tandberg E, Larsen JP, Aarsland D, et al. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996;53:175-9.
33. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991;50:743-55.
34. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.
35. Mayberg HS, Starkstein SE, Peyser CE, et al. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 1992;42:1791-7.
36. Blin J, Vidaihlet MJ, Pillon B, et al. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 1992;7:348-54.
37. Nagashama Y, Fukuyama H, Turjanski N, et al. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. Mov Disord 1997;12:691-6.
38. Sawle GV, Brooks DJ, Marsden CD, et al. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991;114: 541-56.
39. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-92.
40. Kish SJ, Gilbert JJ, Chang LJ, et al. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder. Ann Neurol 1985;17:405-7.